feed,title,long_url,short_url
Benzinga,FDA Accepts Review Of Phathom Pharmaceuticals' NDA For Vonoprazan,https://benzinga.com/general/biotech/22/05/27392234/u-s-fda-accepts-review-of-phathom-pharmaceuticals-nda-for-vonoprazan,https://bit.ly/3PIh3Vq
Benzinga,"This Mid-Cap Firm Can Potentially Offer Biggest Oral Drug In Atopic Dermatitis, Cantor Thinks So",https://benzinga.com/analyst-ratings/analyst-color/22/05/27397792/this-mid-cap-firm-can-potentially-offer-biggest-oral-drug-in-atopic-dermatitis-cant,https://bit.ly/3ac9dD4
